DEPARTMENT OF HEALTH
Addition of Diseases to the Newborn Screening and Follow-Up Program
[43 Pa.B. 1154]
[Saturday, February 23, 2013]
Under section 3(d) of the Newborn Child Testing Act (act) (35 P. S. § 623(d)), the Department of Health (Department), with the approval of the Newborn Screening and Follow-up Technical Advisory Committee (Committee), has the authority to establish by periodic publication in the Pennsylvania Bulletin, changes to the list in section 3(a)(1) of the act of diseases for which screening tests shall be conducted and changes to the list in section 3(a)(2) of the act of diseases for which follow-up services of newborn children with abnormal, inconsistent or unacceptable screening test results are required.
The Department hereby gives notice that, effective July 1, 2013, the following disease shall be added to the list of diseases for which follow-up services (relating to case management, referrals, confirmatory testing and assessments) in section 3(a)(2) of the act of newborn children are required:
Severe Combined Immunodeficiency Disease (SCID).
Persons with a disability who require an alternative format of this notice (for example, large print, audiotape, Braille) should contact the Department of Health, Bureau of Family Health, Division of Newborn Screening Program, 625 Forster Street, H&W Building, 7th Floor East, Harrisburg, PA 17120, (717) 783-8143, for speech and/or hearing impaired persons at V/TT (717) 783-6514, or the Pennsylvania AT&T Relay Service at (800) 654-5984 (TT).
[Pa.B. Doc. No. 13-325. Filed for public inspection February 22, 2013, 9:00 a.m.]
No part of the information on this site may be reproduced for profit or sold for profit.
This material has been drawn directly from the official Pennsylvania Bulletin full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.